|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02329 GLORY HEALTH
Nominal 
0.199 +0.003 (+1.531%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 324,178 | -67.170% | 987,459 | 1,456,867 | 2,946,268 | 6,574,553 |
| Cost of Sales | (319,809) | -42.396% | (555,182) | (1,276,717) | (3,122,585) | (5,526,682) |
| Gross Profit | 4,369 | -98.989% | 432,277 | 180,150 | (176,317) | 1,047,871 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | (269,961) | -- | -- | 94,620 | |
| Change in FV & Impairment on Others | -- | -- | -- | (16,762) | (69,254) | (2,694) | |
| Profit / (Loss) on Disposal | (8,373) | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (5,188) | (11,233) | (1,280) | (9,346) | |
| Profit / (Loss) before Taxation | (188,336) | 50.473% | (125,163) | (285,266) | (854,725) | 824,675 | |
| Taxation | 18,317 | -69.833% | 60,719 | 15,449 | 76,901 | (454,112) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (55,160) | -- | 5,786 | 2,943 | 95,340 | (104,017) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (225,179) | 283.878% | (58,659) | (266,874) | (682,484) | 266,546 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 38,958 | 1.145% | 38,517 | 142,455 | 331,235 | 92,622 |
| Depreciation & Amortisation | 23,502 | -40.872% | 39,748 | 35,498 | 34,784 | 35,076 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | -5.070 | 284.091% | -1.320 | -6.000 | -15.400 | 6.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 2.183 | -- | 2.500 | 2.580 | 2.705 | 2.871 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -225,179 |
| %Change | 283.878% |
| EPS / (LPS) | RMB -0.051 |
| NBV Per Share (¥) | RMB 2.183 |